Catalytic Wealth RIA LLC bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 9,276 shares of the company’s stock, valued at approximately $1,438,000. Several other institutional investors and hedge funds also recently made […]